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Copyright © 200? JCBN Summary Oxidative stress is thought to play a role in the development of insulin resistance.
In order to elucidate the molecular effect of oxidative stress on liver insulin signaling, we
analyzed the effect of paraquat (1,1-dimethyl-4,4-dipyridynium; PQ)-derived oxidative stress
on the expression of insulin-dependent genes and activation of liver insulin signaling pathway.
Incubation of primary cultured rat hepatocytes with 2 mM PQ for 6 h impaired the suppres-
sive effect of insulin on insulin-like growth factor-binding protein-1 (IGFBP-1) gene expres-
sion, but did not influence glucose-6-phosphatase gene expression. Insulin-dependent
phosphorylation or activation of insulin receptor, insulin receptor substrate-1 and -2,
phosphatidylinositol 3-kinase, Akt and forkhead in rhabdomyosarcoma were not affected by
PQ pre-treatment. In contrast, PQ treatment impaired insulin-dependent phosphorylation of
mammalian target of rapamycin (mTOR). These results indicate that PQ-induced oxidative
stress impairs insulin-dependent mTOR activation and that this impairment probably causes
inhibition of insulin-dependent repression of IGFBP-1 expression.
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Introduction
Oxidative stress has been suggested to play an important
role in the development and progression of diabetes.
Increased levels of oxidative products have been detected
in diabetic animals and humans [1–3], and intake of anti-
oxidants improves insulin resistance in vivo [ 4,  5].
Furthermore, induction of oxidative stress by inhibiting
glutathione synthesis in rats has been reported to induce
insulin resistance [6], and overexpression of antioxidative
enzymes in mice reduces insulin resistance induced by
adipocytokines [7].
After insulin binds to its specific cell surface receptor,
insulin receptor (IR) tyrosine kinase is activated, causing
autophosphorylation of IR. Fully activated IR tyrosine
kinase phosphorylates intracellular substrates such as insulin
receptor substrate (IRS)-1 and -2. Tyrosine phosphorylated
IRSs are recognized by SH2-domain containing signaling
molecules, resulting in activation of downstream signaling
pathways including the phosphatidylinositol 3-kinase (PI 3-
kinase) pathway. When this pathway is activated, one of the
downstream Ser/Thr kinases, Akt/PKB, is phosphorylated
at Ser 473 and Thr308, resulting in its activation. Akt/PKBK. Kimura et al.
J. Clin. Biochem. Nutr.
158
phosphorylates various substrates, for example the transcrip-
tion factor forkhead in rhabdomyosarcoma (FKHR), which
is phosphorylated at Ser 249, Ser 256, and Ser 319, inducing
its nuclear export and loss of transcription regulatory activi-
ties to target genes. Another important downstream Ser/Thr
kinase of the PI 3-kinase pathway is mammalian target of
rapamycin (mTOR), which is activated by phosphorylation
of Ser 2448; activated mTOR plays important roles in the
induction of protein synthesis.
The molecular effects of oxidative stress on cellular
insulin signaling have been investigated mainly using adipo-
cytes or muscle cells treated with hydrogen peroxide (H2O2).
The results of those studies have indicated that treatment of
cells with H2O2 inhibits insulin-induced IR phosphorylation
followed by reduced PI 3-kinase activation and glucose up-
take [8–10]. Further investigations have shown that H2O2 or
buthionine sulfoximine, an inhibitor of glutathione synthesis,
depresses insulin-induced phosphorylation of IRS-1 and
activation of PI 3-kinase in low-density microsome fractions
in 3T3-L1 adipocytes and L6 myotube cells [11, 12]. Taken
together, these studies indicate that oxidative stress may
cause impairment of insulin signal transduction by inhibiting
phosphorylation or activation of upstream insulin signaling
molecules in adipose tissue or muscle. However, since the
effect of oxidative stress on liver insulin signaling has not
been well investigated, the effect of reactive oxygen species
(ROS) on hepatic insulin action was examined in this study.
In order to examine the effect of ROS, we used paraquat,
1,1-dimethyl-4,4-dipyridynium (PQ) as a radical generator,
which effectively inhibits hepatic insulin action as well as
H2O2, as we previously reported [13]. PQ is known to
generate paraquat radicals by reduced nichotinamide adenine
dinucleotide phosphate reductase, which is reoxidized by
molecular oxygen and produces superoxide radicals [14–16].
Because of this mechanism of radical generation, PQ is
regarded as an intracellular radical generator and has been
widely used as an experimental ROS generator [17–21].
In this study, we measured the expression of insulin-like
growth factor-binding protein-1 (IGFBP-1) and glucose-6-
phosphatase (G6Pase) genes as indicators of insulin action,
because the expression of these genes is repressed by insulin
in liver or hepatocytes [22]. IGFBP-1 inhibits the growth-
promoting effect of insulin-like growth factors (IGFs) by
binding to IGFs [23], and G6Pase is a rate-limiting enzyme
of hepatic gluconeogenesis. Increased expression of these
genes in animals has been shown to produce insulin resis-
tance or metabolic profiles similar to type 2 diabetes [24,
25]. Although both IGFBP-1 and G6Pase genes are regu-
lated by insulin via transcription factor FKHR, which binds
to the insulin response element in their promoter region
[26–29], the existence of distinct mechanisms has been also
reported [29–34]. In particular, IGFBP-1 gene expression is
regulated by the mTOR-dependent pathway that is distinct
from the regulation of the G6Pase gene [32, 33]. In this
study, we first measured the effect of PQ treatment on the
expression of IGFBP-1 and G6Pase genes, and further
analyzed insulin-induced phosphorylation of IR, IRS-1 and
-2, Akt, mTOR, and FKHR, and insulin-induced PI 3-kinase
activation in order to investigate the molecular effect of PQ
on insulin action in liver.
Materials and Methods
Materials
Williams’ medium E (WE) and Hanks’ balanced-salt
solution (HBSS) were purchased from SIGMA (St. Louis,
MO); newborn bovine serum (NBS) was from JRH Bio-
science (Lenexa, KS); penicillin G, streptomycin sulfate, and
kanamycin were from SIGMA; collagen-coated dishes were
from Asahi Techno Glass Co. (Tokyo, Japan); collagen
(Cellmatrix Type I) and collagenase (Collagenase S-1) were
from Nitta Gelatin Inc. (Osaka, Japan); glycogen (glycogen
type II from Oyster) was from SIGMA; and trypsin inhibitor
was from Wako Pure Chemical Industries Ltd. (Osaka,
Japan). Anti IRS-1, anti-IRS-2, anti-phosphotyrosine (p-Tyr),
anti-FKHR, and secondary antibodies for immunoblotting
were purchased from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA). Anti-phospho-Akt (Ser 473), anti-phospho-
mTOR (Ser 2448), and anti-phopho-FKHR (Ser 256) were
purchased from Cell Signaling Technology, Inc. (Beverly,
MA). Anti-IRS-1 and anti-IRS-2 antibodies for immuno-
precipitation were prepared according to the method
described previously [35]. [γ-32P] ATP (6,000 Ci/mmol) was
purchased from Amersham Pharmacia Biotech (Uppsala,
Sweden). Other chemicals were of reagent grade available
commercially.
Primary cultures of rat liver parenchymal cells
Primary cultured rat hepatocytes were isolated from livers
of male Wistar strain rats (body weight 150–300 g, Japan
Laboratory Animal, Tokyo, Japan) by perfusion with colla-
genase as described previously [36]. Parenchymal cells were
inoculated on collagen-coated dishes at densities of
1.4 × 106 cells/60 mm dish or 4.2 × 106 cells/100 mm dish
and cultured for 2 h in WE with 10% (w/v) NBS, 10 nM
insulin, and 1 μM dexamethasone at 37°C in a humidified
incubator with an atmosphere of 95% air/5% CO2. Cells for
the trypan blue exclusion assay were inoculated on collagen-
coated cover glass at the density described above. All media
contained penicillin (0.1 U/ml), streptomycin (0.1 μg/ml),
and kanamycin (30 μg/ml). Unattached cells were removed
by aspiration 3 h after inoculation, and attached cells were
incubated further for 20–24 h in the same medium. The
medium was then discarded and the cells were washed three
times with HBSS before treatment with various concentra-
tions of PQ in WE containing 0.1% (w/v) bovine serumOxidative Stress Regulates Hepatic Gene Expression
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albumin for an additional period.
Trypan blue exclusion assay
Cell viability was assessed by adding 0.03% (w/v) trypan
blue to the cells and counting dead cells under a light micro-
scope.
Lactate dehydrogenase (LDH) activity assay
Cell culture medium (50–200 μl) was added to 2 ml of
50 mM phosphate buffer (pH 7.5) containing 0.62 mM
lithium pyruvate and 0.18 mM nichotinamide adenine
dinucleotide that had been pre-warmed at 35°C, and the
decreasing rate of absorbance at 340 nm was measured.
LDH activity (unit/ml) was defined as 1 unit = 1720 ×
(decrease in absorbance at 340 nm for 2 min).
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was prepared from the cultured cells as
described previously [37]. cDNA synthesis and polymerase
chain reaction (PCR) were performed as described pre-
viously [13]. PCR with graded amounts of control template
were performed at the same time, and a reaction cycle that
gave quantitative amplification of the control template was
adopted for each reaction. PCR primers used were as fol-
lows: G6Pase sense, 5'-GGTTACTTCTACTCTCGCTATG-
3'; G6Pase antisense, 5'-GCTGGCAAAGGGTGTAGTGT-3';
IGFBP-1 sense, 5'-TCCTGATCCTCCTGTCCTT-3'; IGFBP-
1 antisense, 5'-TATAGAGTTCCCGTTGG-3'; β-actin sense,
5'-ACCCACACTGTGCCCATCTA-3'; β-actin antisense, 5'-
CGTCACACTTCATGATG-3'. The results were quantified
using the public domain NIH Image program.
Immunoblotting
Cells were lysed at 0°C in 0.25 ml of Tris/Triton lysis
buffer [50 mM Tris-HCl pH 7.4, 1% (v/v) triton X-100,
1 mM ethylenediaminetetraacetic acid (EDTA), 150 mM
NaCl, 1 mM NaF, 10% (v/v) glycerol] containing 10 mg/ml
p-nitrophenyl phosphate (PNPP), 10 mM Na3VO4, 20 μg/ml
aprotinin, 20 μg/ml phenylmethylsulfonyl fluoride (PMSF),
10 μg/ml leupeptin, and 5 μg/ml pepstatin, and then centri-
fuged. A fraction of each sample that contained the same
amount of protein was subjected to SDS-PAGE and the
proteins on the gel were transferred to a polyvinylidene
fluoride membrane (Hybond-P, Amersham Bioscience,
Tokyo, Japan) and immunoblotted with a monoclonal anti-
body (1:100 for anti-phosphotyrosine antibody) or polyclonal
antibody (1:500 for anti-IRS-1 antibody, 1:500 for anti-IRS-
2 antibody, 1:100 for anti-phospho-Akt antibody, 1:100 for
anti-phospho-mTOR antibody, and 1:100 for anti-FKHR
antibody). The blots were then probed for 1 h with anti-
mouse IgG (1:3,000), anti-rabbit IgG (1:3,000), or anti-goat
IgG (1:3,000) conjugated with horseradish peroxidase. Pro-
teins were detected using an ECL kit, according to the
manufacturer’s directions (Amersham ECL kit or ECL Plus
kit; Amersham Life Sciences Co.), and the results were
quantified using the public domain NIH Image program.
Immunoprecipitation
Immunoprecipitation was performed by incubating cell
lysate (2.5 mg protein) with anti-IRS-1 or anti-IRS-2 anti-
body (20 μl) bound to protein G sepharose beads for 1.5 h at
4°C. After centrifugation, precipitant was washed three
times with Tris/Triton lysis buffer and boiled for 3 min with
1x Laemmli’s sample buffer to elute immunoprecipitated
proteins.
PI 3-kinase activity assay
Cells were lysed at 0°C in 0.25 ml of Tris/Triton lysis
buffer containing 10 mg/ml PNPP, 10 mM Na3VO4, 20 µg/ml
aprotinin, 20 μg/ml PMSF, 10 μg/ml leupeptin, and 5 μg/ml
pepstatin. The lysate was centrifuged at 3,000 × g for 5 min
at 4°C. The supernatant (500 μg protein) was incubated with
anti-IRS-1 antibody (10 μl) or anti-IRS-2 antibody (10 μl)
overnight at 4°C. Ten microliters of Protein A-Sepharose
(30%, v/v) was then added and the incubation was continued
for 2 h. The immunoprecipitates were collected by centrifu-
gation at 4°C, washed once with Tris/Triton lysis buffer, and
then with LiCl buffer (100 mM Tris-HCl pH 7.5, 500 mM
LiCl), distilled water, TNE buffer (20 mM Tris-HCl pH 7.5,
100 mM NaCl, and 1 mM EDTA), and finally with reaction
buffer (20 mM Tris-HCl pH 7.5, 100 mM NaCl, and 0.5 mM
EDTA). The PI 3-kinase assay was carried out as described
previously [38], with slight modifications. Briefly, the assay
was initiated by preincubation of immunocomplexes in
40 μl of assay mixture I (39.5 μl of reaction buffer with
0.5 μl of phosphatidylinositol) at 25°C for 5 min, to which
was added 10 μl of assay mixture II [100 mM MgCl2, 5 mM
dithiothreitol, 0.15 mM, ATP 1% (v/v) [γ-32P] ATP (4 μCi/
mmol)] and further incubated for 30 min. After incubation,
One hundred microliters of chloroform/methanol/HCl
(10:20:1) was added to the reaction mixture to stop the
reaction. The mixture was centrifuged at 20,100 × g for
5 min at 4°C to extract lipid, spotted on a silica gel plate,
and developed with chloroform/methanol/NH4OH/water
(43:38:6:6). 32P radioactivity incorporated into phosphatidy-
linositol was detected by autoradiography as PI 3-kinase
activity. Each data point represents the mean of three repli-
cate dishes.
Statistical analysis
Each treatment effect was analyzed by Student’s t test, and
differences were considered significant at p<0.05. Statistical
analysis was performed on three samples from identical
preparations of cells and the reproducibility of results was
confirmed by using at least two different preparations.K. Kimura et al.
J. Clin. Biochem. Nutr.
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Results
PQ-induced oxidative stress in primary cultured rat hepato-
cytes
The effect of PQ-induced oxidative stress on cell viability
was evaluated by trypan blue exclusion assay. Incubating
cells with 1 mM or 5 mM PQ within 12 h did not affect cell
viability (Fig. 1A), while incubation with 5 mM PQ for 24 h
decreased cell viability to 50%. Damage of the plasma
membrane, estimated by LDH activity in the cell culture
medium, was increased slightly until 12 h after PQ treatment
and increased remarkably by incubating cells with 5 mM PQ
for 24 h (Fig. 1B).
Effect of PQ on insulin-dependent gene expression
Because insulin is known to reduce hepatic IGFBP-1 and
G6Pase gene expression predominantly [39–42], we analyzed
the effect of PQ on the mRNA content of these genes.
Treatment of the cells with 100 nM insulin for 6 h decreased
the mRNA level of these genes to 20–40% (Fig. 2A). The
suppressive effect of insulin on IGFBP-1 gene expression
was impaired by 2 mM PQ treatment while that on G6Pase
gene expression was not inhibited (Fig. 2A). Co-incubation
with 1 mM N-acetyl-L-cysteine, an antioxidant, almost
completely blocked the effect of PQ on insulin-dependent
repression of IGFBP-1 gene expression (Fig. 2B).
Effect of PQ on insulin-dependent phosphorylation of IR,
IRS-1, and IRS-2
We next examined the effect of PQ on insulin signaling at
the early stage. Treatment of the cells with 100 nM insulin
for 1 min increased tyrosine phosphorylation of IR, IRS-1,
and IRS-2, and the amount of PI 3-kinase p85 subunit
associated with IRS. These effects of insulin were not
affected by pretreatment of the cells with 2 mM or 5 mM PQ
for 6 h (Fig. 3A–F). The amounts of IRS-1 and IRS-2 were
Fig. 1. PQ treatment induced oxidative stress in primary cultured rat hepatocytes. (A) The viability of cells treated with 0, 1, or 5 mM
PQ for 15 min, 6 h, 12 h and 24 h was estimated by trypan blue exclusion assay. (B) Plasma membrane damage of the cells
treated with 0, 2, or 5 mM PQ for 15 min, 6 h, 12 h and 24 h was estimated by measuring LDH activity in the cell culture
medium. Values shown are means ± SEM of three dishes, and expressed as relative values to cells without PQ treatment (PQ
0 mM). *, # Significantly different from cells without PQ treatment (p<0.05).Oxidative Stress Regulates Hepatic Gene Expression
Vol. 46, No. 2, 2010
161
not significantly changed (Fig. 3A and D).
Effects of PQ on insulin-dependent activation of PI 3-kinase
As shown in Fig. 4, treatment of the cells with 100 nM
insulin for 6 h increased PI 3-kinase activity bound to IRS-1
or IRS-2. Pretreatment with PQ slightly reduced insulin-
dependent PI 3-kinase activity by about 20%; however, this
reduction was not statistically significant for PI 3-kinase
activity bound to IRS-1 as well as IRS-2 (Fig. 4).
Effects of PQ on insulin-dependent phosphorylation of Akt
and FKHR
We then examined changes of the downstream signals
along the PI 3-kinase pathway. Treatment of the cells with
100 nM insulin for 1 min increased the phosphorylation of
Akt (Ser 473) which reflects Akt activity (Fig. 5A). Pretreat-
ment with 2 mM or 5 mM PQ for 6 h did not affect insulin-
dependent Akt phosphorylation in the same manner with PI
3-kinase activity bound to IRS-1 and IRS-2. In addition,
treating the cells with 1 μM insulin for 15 min increased
Ser 256 phosphorylation of FKHR, which is one of the
substrates of Akt, and increased transcription of IGFBP-1
and G6Pase genes with the non-phosphorylated form [27,
29]. Pretreatment with 5 mM PQ for 6 h did not inhibit
insulin-dependent FKHR phosphorylation (Fig. 5B).
Effect of PQ on insulin-dependent phosphorylation of mTOR
Last, we measured the activity of another downstream
Ser/Thr kinase, mTOR, by its phosphorylation. Treatment
of the cells with 100 nM insulin for 10 min increased the
phosphorylation of mTOR (Ser 2448). Interestingly, pre-
treatment with 2 mM PQ for 6 h abolished insulin-
dependent mTOR phosphorylation (Fig. 6A). In order to
investigate the role of mTOR in insulin-dependent regulation
of gene expression, we analyzed the effect of rapamycin, an
mTOR inhibitor, on insulin-dependent regulation of IGFBP-
1 and G6Pase mRNA content. As shown in Fig. 6B, regula-
tion of IGFBP-1 by insulin was rapamycin-sensitive while
that of G6Pase was not, indicating that insulin signals
through mTOR play an important role in down-regulation of
the IGFBP-1 mRNA level.
Discussion
PQ produces oxidative stress by redox cycling with a
variety of diaphorases and oxygen to produce supreoxide
radicals [14–16] and was used as an intracellular radical
generator in the present study. PQ treatment for 6 h, the
experimental condition in this study, did not decrease cell
viability and slightly increased leakage of LDH from the
cells (Fig. 1). The effect of PQ-induced oxidative stress was
not so severe as to reduce cell viability and was almost equal
Fig. 2. PQ-derived oxidative stress impairs insulin regulation of the IGFBP-1 mRNA level in primary cultured rat hepatocytes. (A)
Effect of PQ on insulin regulation of IGFBP-1 and G6Pase mRNA level was measured with cells treated with/without 2 mM
PQ, 100 nM insulin for 6 h. Total RNA was prepared from the cells and the mRNA contents of IGFBP-1 and G6Pase were
estimated by RT-PCR. Values shown are relative mRNA levels compared to cells without insulin and PQ treatment (Ins-, PQ
0 mM) and expressed as means ± SEM of three dishes. (B) Effect of NAC on PQ treatment was examined with cells treated
with/without 2 mM PQ, 100 nM insulin and antioxidant NAC simultaneously for 6 h. Values shown are relative IGFBP-1
mRNA levels compared to the cells without PQ, NAC, and insulin treatment (Ins-, NAC 0 mM, PQ 0 mM) and expressed as
means ± SEM of three dishes. #Significantly different from cells without insulin treatment (p<0.05). *Significantly different
between the two groups by PQ or NAC treatment (p<0.05).K. Kimura et al.
J. Clin. Biochem. Nutr.
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to that seen in our previous study, in which we demonstrated
the repressive effect of oxidative stress on insulin regulation
of gene expression [13]. The results of this study showed
that PQ treatment inhibited insulin-dependent regulation of
IGFBP-1 but not G6Pase, suggesting that the effect of PQ
was specific to a signaling pathway that regulates IGFBP-1
gene expression. As the inhibitory effect of PQ on insulin-
dependent regulation of IGFBP-1 gene expression was
repressed by the antioxidant NAC, the effect was mediated
by ROS or changes of intracellular redox status (Fig. 2).
Since PQ is an intracellular radical generator, we assumed
that PQ-derived ROS attacked insulin signaling molecules
Fig. 3. PQ treatment did not affect insulin-dependent phosphorylation of IRSs and association of PI 3-kinase with IRS. (A, D)
Phosphorylation of IRSs and PI 3-kinase association was estimated with primary cultured rat hepatocytes pre-treated with 0, 2,
or 5 mM PQ for 6 h and then treated with/without 100 nM insulin for 1 min. After the protein lysate of the cells was immuno-
precipitated with anti-IRS antibody, the IRS phosphorylation level, IRS-associated PI 3-kinase p85 subunit level, and IRS
protein level were analyzed by immunoblotting with anti-phosphotyrosine (PY-20), anti-p85 and anti-IRS antibodies, respec-
tively. (B, C, E, F) IRS phosphorylation level and the amount of IRS-associated p85 were quantified and expressed as relative
values to cells treated with insulin and without PQ (Ins+, PQ 0 mM). Values are means ± SEM of three dishes. #Significantly
different from cells without insulin treatment (p<0.05). *Significantly different between the two groups by PQ treatment
(p<0.05).Oxidative Stress Regulates Hepatic Gene Expression
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Fig. 4. PQ treatment did not affect insulin-dependent activation of PI 3-kinase. Primary cultured rat hepatocytes were pre-treated with
0, 2, or 5 mM PQ for 6 h and then treated with/without 100 nM insulin for 1 min. Protein lysate was prepared from the cells,
immunoprecipitated with anti-IRS-1 antibody (A) or anti-IRS-2 antibody (B), and PI 3-kinase activity was analyzed by measur-
ing 32P incorporation into phosphatidylinositol (upper panels). 32P incorporated into phophatidylinositol 3,4,5-triphosphate was
quantified and expressed as relative values to cells treated without insulin and PQ (Ins-, PQ 0 mM) (lower panels). Values are
means ± SEM of three dishes. #Significantly different from cells without insulin treatment (p<0.05).
Fig. 5. PQ treatment did not affect insulin-dependent phosphorylation of Akt and FKHR. Primary cultured rat hepatocytes were pre-
treated with 0, 2, or 5 mM PQ for 6 h and then treated with/without insulin for 1 min for Akt and 15 min for FKHR. Protein ly-
sate was prepared from the cells, and Ser 473 phosphorylation of Akt (A) and Ser 256 phosphorylation of FKHR (B) was ana-
lyzed by Western blot analysis with anti-phospho-Akt (Ser 473) or anti-phospho-FKHR (Ser 256) antibody (upper panels).
Phosphorylated levels were quantified and expressed as relative values to cells without insulin and PQ treatment (Ins-, PQ
0 mM) (lower panels). Values are means ± SEM of three dishes. #Significantly different from the cells without insulin treatment
(p<0.05).K. Kimura et al.
J. Clin. Biochem. Nutr.
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before being quenched by cellular antioxidative systems.
Among the intracellular insulin signaling molecules
investigated, our results demonstrated that PQ treatment did
not affect insulin signal transduction at the early stage, such
as phosphorylation of IR and IRS, activation of PI 3-kinase,
and phosphorylation of Akt. In adipocytes and muscle cells,
oxidative stress has been shown to disrupt subcellular
redistribution of IRS-1 and PI 3-kinase induced by insulin
treatment [11, 12]. Since the insulin-induced increase and
activation of IRS-1 and PI 3-kinase in low-density micro-
some fractions is important in glucose transporter 4 trans-
location and glucose uptake in these tissues, impairment of
this process may have an important role in inducing insulin
resistance. In the case of liver, H2O2 has been shown to act as
a stimulator of IR tyrosine kinase by inhibiting protein-
tyrosine-phosphatase activity [43]. These results suggest
that H2O2-derived ROS influences the early stage of insulin
signaling in a tissue-specific manner. As PQ treatment did
not up-regulate the early stages of insulin signaling, such as
phosphorylation of IR, IRS, PI 3-kinase, and Akt/PKB in
this study (Figs. 3, 4, and 5), the severity or duration of ROS
generation may be important to induce the up-regulation of
insulin signaling.
Based on the fact that PQ treatment did not affect insulin-
dependent phosphorylation of FKHR, we conclude that the
effects of PQ treatment on inhibition of insulin-dependent
repression of IGFBP-1 gene expression are not mediated
by the PI 3-kinase-Akt-FKHR pathway. On the other hand,
another interesting target of PQ-induced ROS among insulin
signaling molecules that we found in this study is mTOR.
That is, phosphorylation of mTOR Ser 2448, which reflects
its activation, was impaired by PQ treatment (Fig. 6). Since
the insulin regulation of IGFBP-1 was sensitive to rapamycin
treatment but that of G6Pase was not (Fig. 6B), it is conceiv-
able that the inhibition of insulin-dependent mTOR phos-
phorylation caused impairment of insulin regulation of only
IGFBP-1 gene expression. It has been reported that insulin-
regulation of IGFBP-1 gene expression is not involved in
FKHR binding [34] but is dependent on mTOR activation
[32, 34]. These findings support the present results showing
that inhibition of insulin-dependent mTOR phosphorylation
causes impairment of insulin-dependent regulation of
IGFBP-1 gene expression. This is the first report to indicate
that ROS impairs insulin-dependent mTOR phosphorylation
directly, although it has also been reported that H2O2 impairs
mTOR dependent pathways in hepatocytes [32]. Therefore,
we conclude that insulin-dependent mTOR phosphorylation
is a target of oxidative stress in liver.
Phosphorylation of mTOR is regulated not only by
insulin, but also by growth factors, energy, or the amino acid
Fig. 6. PQ treatment impaired insulin-induced phosphorylation of mTOR. (A) phosphorylation of mTOR was analyzed with primary
cultured rat hepatocytes pre-treated with/without 2 mM PQ for 6 h and then treated with/without 100 nM insulin for 10 min.
Protein lysate was analyzed by Western blot analysis with anti-phospho-mTOR (Ser 2448) antibody. Phosphorylated levels
were quantified and expressed as relative values to cells without insulin and PQ treatment (Ins-, PQ 0 mM). Values are
means ± SEM of three dishes. #Significantly different from the cells without insulin treatment (p<0.05). (B) The effect of
rapamycin treatment on the IGFBP-1 mRNA level was measured by RT-PCR with primary cultured rat hepatocytes treated
with/without 10 nM rapamycin and 1 μM insulin for 6 h simultaneously. Values represent the repressive effect of insulin on the
IGFBP-1 mRNA level (1 μM insulin/0 M insulin) and are expressed as means ± SEM of three dishes. *Significantly different
between the two groups by rapamycin treatment (p<0.05).Oxidative Stress Regulates Hepatic Gene Expression
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supply. Signals from insulin and growth factor receptors via
the PI 3-kinase/Akt pathway phosphorylate and inactivate
tuberous sclerosis complex (TSC) 2 and convert Ras
homolog-enriched in brain to its active GTP-bound form,
leading to activated mTOR [44]. Energy or amino acid
restriction has been reported to impair mTOR phosphoryla-
tion through activation of AMP-activated protein kinase
which can activate TSC2 [45–48]. By these mechanisms,
protein synthesis of cells is regulated in response to nutri-
tional stress using mTOR as an essential regulator. Whether
the same mechanism is involved in the impairment of
mTOR phosphorylation under PQ-induced oxidative stress
is unclear at present. The results of the present study suggest
for the first time that ROS-derived stress suppresses mTOR
phosphorylation as in the case of energy- or amino acid-
deprivation.
The mechanism underlying mTOR regulation of IGFBP-1
gene expression is unknown at present. As a transcription
factor regulated by mTOR, hypoxia-inducible factor-1α has
been reported to regulate IGFBP-1 gene expression in
response to hypoxia in zebra fish [49]. Under hypoxia,
IGFBP-1 mRNA expression is increased through the eleva-
tion of HIF-1α. However, we found that the HIF-1α level in
the cells did not change with PQ treatment (data not shown).
Insulin-dependent mTOR activation may regulate IGFBP-1
gene expression by a different mechanism from that of
hypoxia, and elucidation of this mechanism is in progress
in our laboratory.
The impairment of insulin regulation of IGFBP-1 synthesis
helps maintain hepatic IGFBP-1 synthesis and plasma
IGFBP-1 at higher level, which inhibits the protein synthesis
activity of IGF-I in peripheral tissues. Furthermore, mTOR
by itself is a serine/threonine protein kinase which phos-
phorylates and regulates the activity of eukaryotic transla-
tion initiation factor 4E-binding protein 1 and p70 S6 kinase,
inducing mRNA translation and resulting in an increase in
cellular protein synthesis [50]. Therefore, oxidative stress
may suppress cellular protein synthesis through the inhibi-
tion of insulin-dependent mTOR phosphorylation in hepato-
cytes. The present results therefore suggest a novel mecha-
nism of oxidative stress to down-regulate protein synthesis
via IGFBP-1 production.
In conclusion, PQ-induced oxidative stress impaired
insulin-dependent repression of IGFBP-1 gene expression,
not by changes in tyrosine phosphorylation of IR or IRSs, or
activation of PI 3-kinase and Akt/PKB, but by the impair-
ment of insulin-dependent mTOR activation. The present
study strongly suggests that this novel mechanism of oxida-
tive stress to inhibit mTOR activity leads to a reduction of
whole body protein synthesis through inhibition of IGF
activity by increases in IGFBP-1 as well as inhibition of
mTOR-mediated protein synthesis.
Acknowledgment
We are grateful to Yuka Toyoshima for technical assis-
tance and helpful discussions. This study was supported by a
Grant-in-Aid for Scientific Research from Japanese Ministry
of Education, Culture, Sports, Science and Technology
[(C) 19580150, 2007-2008; A. Takenaka].
Abbreviations
EDTA, ethylenediaminetetraacetic acid; FKHR, forkhead
in rhabdomyosarcoma; G6Pase, glucose-6-phosphatase;
HBSS, Hanks’ balanced-salt solution; IGFBP-1, insulin-like
growth factor-binding protein-1; IGFs, insulin-like growth
factors; IR, insulin receptor; IRS, insulin receptor substrate;
LDH, lactate dehydrogenase; mTOR, mammalian target of
rapamycin; NAC, N-acetyl-L-cystein; NBS, newborn bovine
serum;  PCR, polymerase chain reaction; PI 3-kinase,
phosphatidylinositol 3-kinase; PMSF, phenylmethylsulfonyl
fluoride; PNPP, p-nitrophenyl phosphate; PQ, paraquat, 1,1-
dimethyl-4,4-dipyridynium; ROS, reactive oxygen species;
RT-PCR, reverse transcription-polymerase chain reaction;
TSC2, tuberous sclerosis complex; WE, Wiiliams’ medium E.
References
[1] Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J.,
Armstrong, D., and Nicotera, T.: Oxidative damage to DNA
in diabetes mellitus. Lancet, 347, 444–445, 1996.
[2] Nourooz, Z.J., Rahimi, A., Tajaddini, S.J., Tritschler, H.,
Rosen, P., Halliwell, B., and Betteridge, D.J.: Relationship
between plasma measures of oxidative stress and metabolic
control in NIDDM. Diabetologia, 34, 171–175, 1997.
[3] Baynes, J.W. and Thorpe, S.R.: Role of oxidative stress in
diabetic complications; a new perspective on an old para-
digm. Diabetes, 48, 1–9, 1999.
[4] Paolisso, G., D’Amore, A., Giugliano, D., Ceriello, A.,
Varrricchio, M., and D’Onofrio, F.: Pharmacologic doses of
vitamin E improve insulin action in healthy subjects and non-
insulin-dependent diabetic patients. Am. J. Clin. Nutr., 57,
650–656, 1993.
[5] Faure, P., Rossini, E., Lafond, J.L., Richard, M.J., Favier, A.,
and Halimi, S.: Vitamin E improves the free radical defence
system potential and insulin sensitivity of rats fed high fruc-
tose diets. J. Nutr., 127, 103–107, 1997.
[6] Khamaisi, M., Kavel, O., Rosenstock, M., Porat, M., Yuli,
M., Kaiser, N., and Rudich, A.: Effect of inhibition of
glutathione synthesis on insulin action; in vivo and in vitro
studies using buthionine sulfoxyimine. Biochem. J.,  349,
579–586, 2000.
[7] Houstis, N., Rosen, E.D., and Lander, E.S.: Reactive oxygen
species have a causal role in multiple forms of insulin resis-
tance. Nature, 440, 944–948, 2006.
[8] Hansen, L.L., Ikeda, Y., Olsen, S.S., Busch, A.K., and
Mosthaf, L.: Insulin signaling is inhibited by micromolarK. Kimura et al.
J. Clin. Biochem. Nutr.
166
concentrations of H2O2. J. Biol. Chem., 274, 25078–25084,
1999.
[9] Maddux, B.A., See, W., Lawrence, J.C., Goldfine, A.L.,
Goldfine, I.D., and Evance, J.L.: Protection against oxidative
stress-induced insulin resistance in rat L6 muscle cells by
micromolar concentrations of α-lipoic acid. Diabetes,  50,
404–410, 2001.
[10] Tirosh, A., Rudich, A., Potashnik, R., and Bashan, N.: Oxida-
tive stress impairs insulin but not platelet-derived growth
factor signaling in 3T3-L1 adipocytes. Biochem. J.,  355,
757–763, 2001.
[11] Tirosh, A., Potashnik, R., Bashan, N., and Rudich, A.:
Oxidative stress disrupts insulin-induced cellular redistribu-
tion of insulin receptor substrate-1 and phosphatidylinositol
3-kinase in 3T3-L1 adipocytes. J. Biol. Chem., 274, 10595–
10602, 1999.
[12] Ogihara, T., Asano, T., Katagiri, H., Sakoda, H., Anai, M.,
Shojima, N., Ono, H., Fujishiro, M., Kushiyama, A.,
Fukushima, Y., Kikuchi, M., Noguchi, N., Aburatani, H.,
Gotoh, Y., Komuro, I., and Fujita, T.: Oxidative stress
induces insulin resistance by activating the nuclear factor-kB
pathway and disrupting normal subcellular distribution of
phosphatidylinositol 3-kinase. Diabetologia,  47, 794–805,
2004.
[13] Kimura, K., Tawara, S., Igarashi, K., and Takenaka, A.:
Effect of various radical generators on insulin-dependent
regulation of hepatic gene expression. Biosci. Biotechnol.
Biochem., 71, 16–22, 2007.
[14] Krall, J., Bagley, A.C., Mullenbach, G.T., Hallewell, R.A.,
and Lynch, R.E.: Superoxide mediates the toxicity or
paraquat for cultured mammalian cells. J. Biol. Chem., 263,
1910–1914, 1988.
[15] Clejan, L. and Cederbaum, A.I.: Synergistic interactions
between NADPH-cytochrome P-450 reductase, paraquat, and
iron in the generation of active oxygen radicals. Biochem.
Pharmacol., 38, 1779–1786, 1989.
[16] Shimada, H., Hirai, K.I., Shimamura, E., and Pan, J.:
Mitochondrial NADH-quinone oxidoreductase of the outer
membrane is responsible for paraquat cytotoxicity in rat
livers. Arch. Biochem. Biophys., 351, 75–81, 1998.
[17] Bus, J.S. and Gibson, J.E.: Paraquat: model for oxidant-
initiated toxicity. Environ. Health Perspect., 55, 37–46, 1984.
[18] Olesen, B.T., Clausen, J., and Vang, O.: Characterization of
the transctiprional profile in primary astrocytes after oxida-
tive stress induced by paraquat. Neurotoxicology, 29, 13–21,
2008.
[19] Yeh, S.T., Guo, H.-R., Su, Y.-S., Lin, H.-J., Hou, C.-C., Chen,
H.-M., Chang, M.-C., and Wang, Y.-J.: Protective effects of
N-acetylcycteine treatmenet post acute paraquat intoxication
in rats and in human lung epithelial cells. Toxicology, 223,
181–190, 2006.
[20] Choi, H.S., An, J.J., Kim, S.Y., Lee, S.H., Kim, D.W., Yoo,
K.-Y., Won, M.H., Kan, T.-C., Kwon, H.J., Kang, J.H., Cho,
S.-W., Kwon, O.-S., Park, J., Eum, W.S., and Choi, S.Y.:
PEP-1-SOD fusion protein efficiently protects against
paraquat-induced dopaminergic neuron damage in a Parkinson
disease mouse model. Free Radic. Biol. Med.,  41, 1058–
1068, 2006.
[21] Hausburg, M.A., DeKrey, G.K., Salmen, J.J., Oallic, M.R.,
and Gardiner, C.S.: Effects of paraquat on development of
preimplantation embryos in vivo and in vitro.  Reprod.
Toxicol., 20, 239–246, 2005.
[22] O’Brien, R.M. and Granner, D.K.: Regulation of gene
expression by insulin. Physiol. Rev., 76, 1109–1161, 1996.
[23] Hwa, V., Oh, Y., and Rosenfeld, R.G.: The insulin-like
growth factor-binding protein (IGFBP) superfamily. Endocr.
Rev., 20, 761–787, 1999.
[24] Rajkumar, K., Krsek, M., Dheen, S.T., and Murphy, L.J.:
Impaired glucose homeostasis in insulin-like growth factor
binding protein-1 transgenic mice. J. Clin. Invest., 98, 1818–
1825, 1996.
[25] Trinh, K.Y., O’Doherty, R.M., Anderson, P., Lange, A.J., and
Newgard, C.B.: Pertubationof fuel homeostasis caused by
overexpression of the glucose-6-phosphatase catalytic subunit
in liver of normal rats. J. Biol. Chem., 273, 31615–31620,
1998.
[26] Cichy, S.B., Uddin, S., Danilkovich, A., Guo, S., Klippel, A.,
and Unterman, T.G.: Protein kinase B/Akt mediates effects of
insulin on hepatic insulin-like growth factor-binding protein-
1 gene expression through a conserved insulin response
sequence. J. Biol. Chem., 273, 6482–6487, 1998.
[27] Durham, S.K., Suwanichkul, A., Scheimann, A.O., Yee, D.,
Jackson, J.G., Barr, F.G., and Powell, D.R.: FKHR binds the
insulin response element in the insulin-like growth factor
binding protein-1 promoter. Endocrinology, 140, 3140–3146,
1999.
[28] Kops, G.J., de Ruiter, N.D., DeVries-Smith, A.M., Powell,
D.R., Bos, J.L., and Burgering, B.M.: Direct control of the
forkhead transcription factor AFX by protein kinase B.
Nature, 398, 630–634, 1999.
[29] Barthel, A., Schmoll, D., Kruger, K.-D., Bahrenberg, G.,
Walther, R., Roth, R.A., and Joot, H.-G.: Differential regula-
tion of endogenous glucose-6-phosphatase and phospho-
enolpyruvate carboxykinase gene expression by the forkhead
transcription factor FKHR in H4IIE-hepatoma cells. Biochem.
Biophys. Res. Commun., 285, 897–902, 2001.
[30] Streeper, R.S., Eaton, E.M., Ebert, D.H., Chapman, S.C.,
Svitek, C.A., and O’Brien, R.M.: Hepatocyte nuclear factor-1
acts as an accessory factor to enhance the inhibitory action of
insulin on mouse glucose–6-phosphatase gene transcription.
Proc. Natl. Acad. Sci. U.S.A., 95, 9208–9213, 1998.
[31] Patel, S., Lochhead, P.A., Rena, G., and Sutherland, C.:
Antagonistic effects of phorbol esters on insulin regulation of
insulin-like growth factor-binding protein-1 (IGFBP-1) but
not glucose-6-phosphatase gene expression. Biochem. J.,
359, 611–619, 2001.
[32] Patel, S ., Rena, G., Fumagalli, S., Pende, M., Kozma, S.C.,
Thomas, G., and Sutherland, C.: Insulin regulation of insulin-
like growth factor-binding protein-1 gene expression is
dependent on the mammalian target of rapamycin, but inde-
pendent of ribosomal S6 kinase activity. J. Biol. Chem., 277,
9889–9895, 2002.
[33] Patel, S., Van Der Kaay, J., and Sutherland, C.: Insulin regu-
lation of hepatic insulin-like growth factor-binding protein-1Oxidative Stress Regulates Hepatic Gene Expression
Vol. 46, No. 2, 2010
167
(IGFBP-1) gene expression and mammalian target of rapa-
mycin (mTOR) signaling is impaired by the presence of
hydrogen peroxide. Biochem. J., 365, 537–545, 2002.
[34] Petal, S., Lipina, C., and Sutherland, C.: Different mecha-
nisms are used by insulin to repress three genes that contain a
homologous thymidine-rich insulin response element. FEBS
Letters, 549, 72–76, 2003.
[35] Ogihara, T., Shin, B.C., Ani, M., Katagiri, H., Inukai, K.,
Funaki, M., Fukushima, Y., Ishihara, H., Takata, K., Kikuchi,
M., Yazaki, Y., Oka, Y., and Asano, T.: Insulin receptor sub-
strate (IRS)-2 is dephosphorylated more rapidly than IRS-1
via its association with phosphatidylinositol 3-kinase in
skeletal muscle cells. J. Biol. Cell, 272, 12868–12873, 1997.
[36] Kato, H., Takahashi, S.-I., Takenaka, A., Funabiki, R.,
Noguchi, T., and Naito, H.: Degradation of endogenous
proteins and internalized asialofetuin in primary cultured
hepatocytes of rats. Int. J. Biochem., 21, 483–495, 1989.
[37] Chopmczynski, P. and Sacchi, N.: Single-step method of
RNA isolation by acid guanidium thiocyanate-phenol-
chloroform extraction. Anal. Biochem., 162, 156–159, 1987.
[38] Carpenter, C.L., Duckworth, B.C., Auger, K.R., Cohen, B.,
Schaffhausen, B.S., and Cantley, L.C.: Purification and
characterization of phosphoinositide 3-kinase from rat liver.
J. Biol. Chem., 265, 19704–19711, 1990.
[39] Unterman, T.G., Oehler, D.T., Murphy, L.J., and Lacson,
R.G.: Multihormonal regulation of insulin-like growth factor-
binding protein-1 in rat H4IIE hepatoma cells: the dominant
role of insulin. Endocrinology, 128, 2693–2701, 1991.
[40] Powell, D.R., Suwanichkulk, A., Cubbage, M.L., DePaolis,
L.A., Snuggs, M.B., and Lee, P.D.K.: Insulin inhibits
transctiprion of the human gene for insulin-like growth
factor-binding protein-1. J. Biol. Chem., 266, 18868–18876,
1991.
[41] Orlowski, C.C., Ooi, G.T., Brown, D.R., Yan, Y.W., Tseng,
L.Y., and Rechler, M.M.: Insulin rapidly inhibits insulin-like
growth factor-binding protein-1 gene expression in H4-II-E
rat hepatoma cells. Mol. Endocrinol., 5, 1180–1187, 1991.
[42] Streeper, R.S., Svitek, C.A., Chapman, S., Greenbaum, L.E.,
Taub, R., and O’Brien, R.M.: A multicomponent insulin
response sequence mediates a strong repression of mouse
glucose-6-phosphatase gene transcriptin by insulin. J. Biol.
Chem., 282, 11398–11701, 1997.
[43] Mahadev, K., Zilbering, A., Zhu, L., and Goldstein, B.J.:
Insulin-stimulated hydrogen peroxide reversibly inhibits pro-
tein-tyrosine phosphatase 1B in vivo and enhances the early
insulin action cascade. J. Biol. Chem., 276, 21938–21942,
2001.
[44] Sarbassov, D.D., Ali, S.M., and Sabatini, D.M.: Growing
roles for the mTOR pathway. Curr. Opin. Cell Biol., 17, 596–
603, 2005.
[45] Cheng, S.W.Y., Fryer, L.G.D., Carling, D., and Shepherd,
P.R.: The2446 is a novel mammalian target of rapamaycin
(mTOR) phosphorylation site regulated by nutrient status. J.
Biol. Chem., 279, 15719–15722, 2004.
[46] Long, X., Ortiz-Vega, S., Lin, Y., and Avruch, J.: Rheb
binding to mammalian target of rapamycin (mTOR) is regu-
lated by amino acid sufficiency. J. Biol. Chem., 280, 23433–
23436, 2005.
[47] Smith, E.M., Finn, S.G., Tee, A.R., Browne, G.J., and Proud,
C.G.: The Tuberous sclerosis protein TSC2 is not required for
the regulation of the mammalian target of rapamycin by
amino acid and certain cellular stresses. J. Biol. Chem., 280,
18717–18727, 2005.
[48] Sofer, A., Lei, K., Johannessen, C.M., and Ellisen, L.W.:
Regulation of mTOR and cell growth in response to energy
stress by REDD1. Mol. Cell Biol., 25, 5834–5845, 2005.
[49] Kajimura, S., Aida, K., and Duan, C.: Understanding
hypoxia-induced gene expression in early development: in
vitro and in vivo analysis of hypoxia-inducible factor 1-
regulated zebra fish insulin-like growth factor binding pro-
tein 1 gene expression. Mol. Cell Biol., 26, 1142–1155, 2006.
[50] Proud, C.G.: Signalling to translation: how signal transduc-
tion pathways control the protein synthetic machinery.
Biochem. J., 403, 217–234, 2007.